Prevalence and Clinical Characteristics of High-Altitude Polycythemia in Panjshir Province, Afghanistan: A Retrospective Hospital-Based Cross-Sectional Study

Main Article Content

Farid Arman
Sayed Musa Danish
Nasratullah Orya Khil
Marina Kiseleva

Abstract

Background: We aimed to review the hospital records to describe polycythemia among adult patients tested at Rukha 50-Bed Hospital in Panjshir Province, Afghanistan.


Methods: This retrospective, hospital-based cross-sectional study reviewed records from Jan 2021 to Sep 2025. We report 2500 adults who underwent complete blood count testing, of whom 650 met the study hemoglobin thresholds (≥21 g/dL in men and ≥19 g/dL in women). Demographic and clinical information was extracted from medical records. Descriptive analyses and chi-square tests were planned using Jamovi version 2.6.44.0.


Results: Of 2,500 patients included over four years, the majority were male (75%-80%). Clear Geographical Clinical Characteristics was observed with polycythemia prevalence highest in the high-altitude districts of Paryan (>3500 m) followed by Dara (~3558 m) and Abshar at lower elevations. Paryan District accounted for the largest share of the study population (37.3%), followed by Dara (34.9%) and Abshar (27.8%). After adjusting for age, sex, and SpO₂, residence in high-altitude districts was independently associated with a 3- to 5-fold increased odds of polycythemia. Male sex and low oxygen saturation were confirmed as independent risk factors, consistent with the known physiological effects of testosterone on erythropoiesis and chronic hypoxia on the HIF-EPO pathway.


Conclusion: Polycythemia is highly prevalent in Panjshir Province, with a clear concentration in districts above 3500 m, such as Paryan. These findings represent the first systematic hospital-based evidence of altitude-associated polycythemia in Afghanistan and provide important baseline data for targeted screening and preventive interventions.


 


Keywords: High-altitude polycythemia; Excessive erythrocytosis; Afghanistan; Retrospective study; Hospital-based study

Article Details

Section
Original Research

References

1. Tefferi A, Barbui T. Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management. Am J Hematol. 2023;98(9):1465-87.

2. Spivak JL. Advances in polycythemia vera and lessons for acute leukemia. Best Pract Res Clin Haematol. 2021;34(4):101330.

3. Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell. 2012;148(3):399-408.

4. Bärtsch P, Swenson ER. Clinical practice: Acute high-altitude illnesses. N Engl J Med. 2013;368(24):2294-302.

5. León-Velarde F, Maggiorini M, Reeves JT, Aldashev A, Asmus I, Bernardi L, et al. Consensus statement on chronic and subacute high altitude diseases. High Alt Med Biol. 2005;6(2):147-57.

6. Villafuerte FC, Corante N. Chronic Mountain Sickness: Clinical Aspects, Etiology, Management, and Treatment. High Alt Med Biol. 2016;17(2):61-9.

7. Winslow RM, Cassinelli CM. Hypoxia, Polycythemia, and Chronic Mountain Sickness: Johns Hopkins University Press; 1987.

8. Monge C, León-Velarde F. Physiological adaptation to high altitude: oxygen transport in mammals and birds. Physiol Rev. 1991;71(4):1135-72.

9. Simonson TS, Yang Y, Huff CD, Yun H, Qin G, Witherspoon DJ, et al. Genetic evidence for high-altitude adaptation in Tibet. Science. 2010;329(5987):72-5.

10. Bigham AW, Lee FS. Human high-altitude adaptation: forward genetics meets the HIF pathway. Genes Dev. 2014;28(20):2189-204.

11. Ran L, Li Y, Liao D, Chen Z, Wang G, Zhang Y. Association between EPAS1 and ATP6V1E2 polymorphisms and susceptibility to high altitude polycythemia in Chinese Tibetan population. Front Med. 2026;12:1737704.

12. Penaloza D, Arias-Stella J. The heart and pulmonary circulation at high altitudes: healthy highlanders and chronic mountain sickness. Circulation. 2007;115(9):1132-46.

13. Al-Kubati M, Al-Kubati AS, al'Absi M, Fiser B. The short-term effect of water-pipe smoking on the baroreflex control of heart rate in normotensives. Auton Neurosci. 2006;126-127:146-9.

14. Beall CM. Two routes to functional adaptation: Tibetan and Andean high-altitude natives. Proc Natl Acad Sci U S A. 2007;104 Suppl 1(Suppl 1):8655-60.

15. Le M, Ghazawi FM, Rahme E, Alakel A, Netchiporouk E, Savin E, et al. Identification of significant geographic clustering of polycythemia vera cases in Montreal, Canada. Cancer. 2019;125(22):3953-9.

16. Sajood MK, Safi AG. Climate change impact on glacier lakes in Panjshir province of Afghanistan. J Environ Sci Revolution. 2020:7-17.

17. Yang M, Zhu Y, Liu L, Pan C, Li L, Su Q, et al. Demographics, clinical features, and comorbidities of high-altitude polycythaemia: a multicentre, retrospective, observational study. J Global Health. 2026;16:04042.

18. Sediqmal M, Sultan H, Patyal S. Flood frequency analysis & modeling and finding flood hazard areas of Panjshir watershed. Int J Res Adv Engin Technol. 2020;6(2):8-13.

19. Zheng GP, Nian W, Shi XF, Xie YB. [Progress in multiomics research on high altitude polycythemia]. Zhonghua Xue Ye Xue Za Zhi. 2024;45(8):795-800.

20. Moore LG. Measuring high-altitude adaptation. J Appl Physiol (1985). 2017;123(5):1371-85.

21. Julian CG, Moore LG. Human Genetic Adaptation to High Altitude: Evidence from the Andes. Genes (Basel). 2019;10(2).

22. Ismailzada H, Ghorbani M, Fayez SM. Hematological Disorders in Afghanistan: A Review. Indian J Hematol Blood Transfusion. 2026:1-8.

23. Jeong C. The genetic history and adaptations of high altitude east Asians in the Tibetan Plateau: The University of Chicago; 2016.

24. Zhou X, Bao Q, Cui Y, Li X, Yang C, Yang Y, et al. Life destiny of erythrocyte in high altitude erythrocytosis: mechanisms underlying the progression from physiological (moderate) to pathological (excessive) high-altitude erythrocytosis. Front Genet. 2025;16:1528935.

25. Van Meter KC, Christiansen LE, Delwiche LD, Azari R, Carpenter TE, Hertz‐Picciotto I. Geographic distribution of autism in California: a retrospective birth cohort analysis. Autism Res. 2010;3(1):19-29.

26. Kumar R. A Comprehensive Guide on High Altitude Medicine: Notion Press; 2026.

27. Gray OA. Analysis of Tibetan Genetic Adaptation and Its Functional Consequences in Multiple, Hypoxia-Responsive Cell Types: The University of Chicago; 2021.

28. Warren AM, Grossmann M. Haematological actions of androgens. Best Pract Res Clin Endocrinol Metab. 2022;36(5):101653.

29. Akpoka O, Omisakin F, Mekomah H. Management practices, challenges and approaches to clinical complications of polycythemia Vera in tertiary healthcare institutions in Nigeria: A narrative review.

30. Corante N, Anza-Ramírez C, Figueroa-Mujíca R, Macarlupú JL, Vizcardo-Galindo G, Bilo G, et al. Excessive Erythrocytosis and Cardiovascular Risk in Andean Highlanders. High Alt Med Biol. 2018;19(3):221-31.

31. Yin R, Wu Y, Li M, Liu C, Pu X, Yi W. Association between high-altitude polycythemia and hypertension: a cross-sectional study in adults at Tibetan ultrahigh altitudes. J Hum Hypertens. 2024;38(7):555-60.

32. Wu TY. Chronic mountain sickness on the Qinghai-Tibetan plateau. Chin Med J (Engl). 2005;118(2):161-8.

33. Beall CM, Cavalleri GL, Deng L, Elston RC, Gao Y, Knight J, et al. Natural selection on EPAS1 (HIF2alpha) associated with low hemoglobin concentration in Tibetan highlanders. Proc Natl Acad Sci U S A. 2010;107(25):11459-64.

34. Song Z, Zhang A, Luo J, Xiong G, Peng H, Zhou R, et al. Prevalence of High-Altitude Polycythemia and Hyperuricemia and Risk Factors for Hyperuricemia in High-Altitude Immigrants. High Alt Med Biol. 2023;24(2):132-8.

35. Petousi N, Croft QP, Cavalleri GL, Cheng HY, Formenti F, Ishida K, et al. Tibetans living at sea level have a hyporesponsive hypoxia-inducible factor system and blunted physiological responses to hypoxia. J Appl Physiol (1985). 2014;116(7):893-904.

36. Jiang C, Liu F, Luo Y, Li P, Chen J, Xu G, et al. Gene expression profiling of high altitude polycythemia in Han Chinese migrating to the Qinghai-Tibetan plateau. Mol Med Rep. 2012;5(1):287-93.

37. Beall CM, Decker MJ, Brittenham GM, Kushner I, Gebremedhin A, Strohl KP. An Ethiopian pattern of human adaptation to high-altitude hypoxia. Proc Natl Acad Sci U S A. 2002;99(26):17215-8.

38. Murphy WG. The sex difference in haemoglobin levels in adults - mechanisms, causes, and consequences. Blood Rev. 2014;28(2):41-7.

39. He B, Feng J, Shu Y, Yang L, He Z, Liao K, et al. Prevalence and Risk Factors of Hyperuricemia Among Young and Middle-Aged Tibetan Men Living at Ultrahigh Altitudes: A Cross-Sectional Study. High Alt Med Biol. 2024;25(1):42-8.

40. Rusak T, Misztal T, Piszcz J, Tomasiak M. Nitric oxide scavenging by cell-free hemoglobin may be a primary factor determining hypertension in polycythemic patients. Free Radic Res. 2014;48(2):230-8.

41. Cinar Y, Demir G, Paç M, Cinar AB. Effect of hematocrit on blood pressure via hyperviscosity. Am J Hypertens. 1999;12(7):739-43.

42. Krishnamoorthy P, Gopalakrishnan A, Mittal V, Kalla A, Slipczuk L, Rangaswami J, et al. Gaisböck syndrome (polycythemia and hypertension) revisited: results from the national inpatient sample database. J Hypertens. 2018;36(12):2420-4.

43. Hancco Zirena I, Florez Prada A, Rojas Bolivar DE, Marengo A, Micha Y, Doutreleau S, et al. High Altitude Headache in Highlanders: A Hallmark Symptom of Chronic Mountain Sickness Related to Excessive Erythrocytosis? A Preliminary Report from the World's Highest City. Wilderness Environ Med. 2026;37(1):64-9.

44. Perger E, Baillieul S, Esteve F, Pichon A, Bilo G, Soranna D, et al. Nocturnal hypoxemia, blood pressure, vascular status and chronic mountain sickness in the highest city in the world. Ann Med. 2022;54(1):1884-93.

45. Jefferson JA, Escudero E, Hurtado ME, Kelly JP, Swenson ER, Wener MH, et al. Hyperuricemia, hypertension, and proteinuria associated with high-altitude polycythemia. Am J Kidney Dis. 2002;39(6):1135-42.

46. Liu X, Yang C, Zhang X, Ye R, Li X, Zhang Z, et al. Association between hemoglobin concentration and hypertension risk in native Tibetans at high altitude. J Clin Hypertens (Greenwich). 2024;26(1):17-23.

47. Guan W, Ga Q, Li R, Bai ZZ, Wuren T, Wang J, et al. Sleep disturbances in long-term immigrants with chronic mountain sickness: a comparison with healthy immigrants at high altitude. Respir Physiol Neurobiol. 2015;206:4-10.

48. Li Z, Hu Q, Ji W, Fan Q. Prevalence of stroke and associated risk factors: a population-based cross-sectional study from the Qinghai-Tibet Plateau of China. BMJ Open. 2022;12(11):e065605.

49. Adams E, Peel T. Chronic Mountain Sickness: A Comprehensive Review of Current Management and Proposals for Novel Therapies. High Alt Med Biol. 2025;26(3):318-27.

50. Liu Q, Li YF. Spatial and temporal analysis of viral hepatitis in mainland China from 2007 to 2023: implications for targeted public health interventions. Front Public Health. 2025;13:1660415.

51. Urdea M, Penny LA, Olmsted SS, Giovanni MY, Kaspar P, Shepherd A, et al. Requirements for high impact diagnostics in the developing world. Nature. 2006;444(Suppl 1):73-9.

52. Luquis RR, Pérez MA. Cultural competence in health education and health promotion: John Wiley & Sons; 2021.